944 results on '"Bonavita, Simona"'
Search Results
2. ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis
3. Identifying definite patterns of unmet needs in patients with multiple sclerosis using unsupervised machine learning
4. Clinical implications for the association of psoriasis and multiple sclerosis: an observational study
5. Signs and symptoms of COVID‐19 in patients with multiple sclerosis
6. Assisted Reproductive Technology and Disease Management in Infertile Women with Multiple Sclerosis
7. Viral pericarditis following ocrelizumab in a multiple sclerosis patient
8. Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study
9. NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab
10. MRI and steroid-responsive encephalopathy associated with autoimmune thyroiditis: first report of conus medullaris involvement and literature review of the known neuroimaging profiles
11. The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis
12. Validation of the swallowing disturbance questionnaire in people with multiple sclerosis
13. Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals’ perspective
14. Machine learning techniques for prediction of multiple sclerosis progression
15. Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8 + T-Cell Proliferation in Patients With Multiple Sclerosis
16. Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study
17. Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis
18. Validation of an iPad version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)
19. Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumab
20. Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic
21. Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study
22. Sex effects across the lifespan in women with multiple sclerosis
23. Reduced clinical connectome fingerprinting in multiple sclerosis predicts fatigue severity
24. Telemedicine application to headache: a critical review
25. Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic
26. Source of medical information and behavioral seeking patterns in patients affected with Friedreich’s ataxia and their caregivers: a survey study
27. Pain, quality of life, and religiosity in people with multiple sclerosis
28. Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study
29. Flexibility of brain dynamics is increased and predicts clinical impairment in relapsing-remitting but not in secondary progressive multiple sclerosis
30. Vitamin D Supplementation: Effect on Cytokine Profile in Multiple Sclerosis
31. Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study
32. PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study
33. Disability assessment using Google Maps
34. Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic
35. Between-sex variability of resting state functional brain networks in amyotrophic lateral sclerosis (ALS)
36. Effectiveness and Safety of CGRP-mAbs in Menstrual-Related Migraine: A Real-World Experience
37. The progressive loss of brain network fingerprints in Amyotrophic Lateral Sclerosis predicts clinical impairment
38. Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8+ T-Cell Proliferation in Patients With Multiple Sclerosis.
39. Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis.
40. Hippocampal connectivity in Amyotrophic Lateral Sclerosis (ALS): more than Papez circuit impairment
41. Exercise and Parkinson’s Disease
42. Apparently isolated CNS involvement in Erdheim-Chester disease: Case report
43. Exploring Circulating Long Non-Coding RNAs in Mild Cognitive Impairment Patients’ Blood
44. Singular cases of Alzheimer’s disease disclose new and old genetic “acquaintances”
45. MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study
46. Correction to: Pain, quality of life, and religiosity in people with multiple sclerosis
47. Coping strategies in relapsing–remitting multiple sclerosis non-depressed patients and their associations with disease activity
48. Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study
49. Psychiatric disorders in multiple sclerosis
50. Cost-Analysis of Telemedicine Interventions Compared with Traditional Care in the Management of Chronic Neurological Diseases: A Systematic Review.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.